Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (48.8), the stock would be worth ₹12 665.8 (64% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 29.8 | ₹7 741.5 |
0%
|
| 3-Year Average | 48.8 | ₹12 665.8 |
+64%
|
| 5-Year Average | 47.7 | ₹12 374.45 |
+60%
|
| Industry Average | 29.5 | ₹7 652.84 |
-1%
|
| Country Average | 17.7 | ₹4 584.05 |
-41%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
₹1.2T
|
/ |
Jan 2026
₹38.6B
|
= |
|
|
₹1.2T
|
/ |
Mar 2026
₹37.8B
|
= |
|
|
₹1.2T
|
/ |
Mar 2027
₹46.1B
|
= |
|
|
₹1.2T
|
/ |
Mar 2028
₹55.2B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 29.8 | 61.6 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
108.2B USD | 9.5 | 15.9 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 31.9 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.8B ZAR | 9.4 | 14.2 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
78.2B MYR | 15.3 | 37.2 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.8B ZAR | 18.2 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
83.5B BRL | 7.6 | 17.8 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
16.4B USD | 5.7 | 11.7 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
97.1B CNY | 21.4 | 30.2 | |
| US |
|
Universal Health Services Inc
NYSE:UHS
|
11.1B USD | 5.7 | 7.4 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
11B USD | 19.7 | 31.6 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 11.9 |
| Median | 17.7 |
| 70th Percentile | 27.8 |
| Max | 47 834.4 |
Other Multiples
Apollo Hospitals Enterprise Ltd
Glance View
In the bustling corridors of Indian healthcare, Apollo Hospitals Enterprise Ltd. stands as a beacon of innovation and quality healthcare service. Founded in 1983 by Dr. Prathap C. Reddy, Apollo was one of the pioneers in bringing private healthcare to India, setting a new benchmark for service standards in the industry. It positioned itself as a leader by establishing a network of nearly 70 hospitals across the nation, offering a comprehensive range of services from routine and preventive care to complex surgeries and cancer treatments. This extensive network allows Apollo to capitalize on economies of scale, optimize resource allocation, and deliver cost-effective healthcare solutions. Its sophisticated hospitals often boast the latest medical technologies and employ highly trained healthcare professionals, ensuring patients receive top-notch care. Beyond its core hospital operations, Apollo has diversified its revenue streams through pharmacies, primary care and diagnostic clinics, telemedicine, and healthcare consulting. The pharmacy business, with a massive network of stores, not only serves walk-in customers but also acts as a critical logistical backbone for the hospitals, providing an integrated supply of medicines and healthcare products. This vertical integration ensures availability and enhances the patient experience while contributing significantly to the company’s bottom line. By embracing a digital-first approach, Apollo's telemedicine and health tech investments are bridging gaps in healthcare accessibility, particularly for rural or underserved populations. Altogether, Apollo Hospitals Enterprise Ltd. has created a robust model that not only addresses the healthcare needs of millions but also consistently generates substantial revenue growth.